The use of bone marrow mononuclear cells (BMMCs) has been shown as a putative efficient therapy for stroke. However, the mechanisms of therapeutic action are not yet completely known. Mannose receptor (MR) is a subgroup of the C-type lectin receptor superfamily involved in innate immune response in several tissues. Although known primarily for its immune function, MR also has important roles in cell migration, cell debris clearance and tissue remodeling during inflammation and wound healing. Here we analyzed MR expression in brains of rats one week after induction of unilateral focal cortical ischemia by thermocoagulation in blood vessels of sensorimotor cortex. Additionally, we evaluated possible changes in such expression in cortices of rats subjected to ischemia plus treatment with BMMCs. Our results showed high expression of MR in an unknown GFAP + cell type and in phagocytic macrophages/microglia within the lesion boundary zone whereas in the noninjured (contralateral) cortical parenchyma, low levels of MR expression were observed.
Introduction
Systemic administration of bone marrow-derived cells is a promising strategy to treat stroke. Beneficial effects of these cells have been described in animal models of ischemic stroke (Brenneman et al., 2010; Chopp and Li, 2002; de Vasconcelos dos Santos et al., 2010; Giraldi-Guimarães et al., 2009; Iihoshi et al., 2004; Kamiya et al., 2008; Mezey, 2007) . Moreover, the feasibility and safety of therapy for stroke in humans with autologous bone marrow cells have already been demonstrated in clinical studies (Bang et al., 2005; Barbosa da Fonseca et al., 2010; Battistella et al., 2011; Savitz et al., 2011) .
Transplantation of bone marrow mononuclear cells (BMMCs) has been shown to be an effective protocol for cell therapy, since BMMCs can be obtained without cultivation and can be harvested in 1.5-6 h for autologous administration (Battistella et al., 2011; Brenneman et al., 2010; Iihoshi et al., 2004; Savitz et al., 2011) . Thus, treatment can be performed during acute phase of stroke (Mendez-Otero et al., 2007) . BMMCs are a heterogeneous cell fraction composed by hematopoietic stem, progenitor and differentiated cells, mesenchymal stem cells and endothelial progenitor cells (Orkin, 2000; Pittenger et al., 1999; Wang et al., 2008; Weissman et al., 2001 ). This cell composition gives to BMMCs important therapeutic features, such as multipotentiality, chemoattractiveness to lesioned tissues and capacity to produce and release many cytokines and trophic factors (Chopp and Li, 2002; Crain et al., 2005; Kawamoto and Losordo, 2008; Krause et al., 2001; Shyu et al., 2006) . In fact, BMMC mechanisms of protection in brain ischemia have been shown to involve mainly chemoattraction to lesion and local paracrine action, by release of many anti-inflammatory, angiogenic and neuroprotective factors (Mendez-Otero et al., 2007) . However, the whole mechanism is currently being discovered and all restorative processes triggered by BMMC paracrine action are still not completely known.
Here we investigated a possible effect of BMMC treatment in tissue clearance in cerebral ischemia. For this reason, we analyzed the expression of mannose receptor (MR), an important player in this process. Mannose receptor (MR) is a subgroup of the C-type lectin receptor superfamily involved in innate immune response in several tissues, including nervous tissue (Linehan et al., 1999) . MR is a constitutive receptor, which under influence of immune mediators acts as a pivotal molecule in the host defense mechanism, being a link between innate and adaptive immunity (Areschoug and Gordon, 2008) . Although MR is known primarily for its innate immune function, it also has an important role in cell migration, intracellular signaling, cell debris clearance and tissue remodeling during inflammation and wound healing (Gazi and Martinez-Pomares, 2009; Taylor et al., 2005) .
Thus, we analyzed MR expression in the cerebral cortex of rats that underwent focal ischemia induced by thermocoagulation of blood vessels in primary motor and somatosensory cortices. Additionally, we evaluated possible changes in cortical pattern of MR expression in rats subjected to cortical ischemia followed by treatment with BMMCs. We chose the time window of a week after ischemia induction for our analyses. This post-ischemia time is likely close to the end of the acute phase, since the cortical tissue is almost degenerated, but not completely (Szele et al., 1995) , and inflammatory events and clearance are still occurring. Moreover, recent reports have suggested that systemically injected BMMCs migrate to an injured cortex as fast as 1 h after injection, but they undergo progressive death, being almost absent in an ischemic lesion 7 days after injection (Brenneman et al., 2010) . We repeated the previously used protocol of treatment 24 h after ischemia induction (Giraldi-Guimarães et al., 2009) . Our rationale was to perform analysis in a time point still inside the acute phase, but with as few as possible exogenous BMMCs. Since the mononuclear fraction contains monocytes with potential to differentiate in MR-expressing macrophages, their presence in earlier time points could mask the intensity of MR expression by endogenous cells within the ischemic lesion.
Results
In accordance with previous descriptions (de Vasconcelos dos Santos et al., 2010; Giraldi-Guimarães et al., 2009) , our procedure of thermocoagulation induced a consistent ischemic lesion that included the six cortical layers, sparing white matter (Fig. 1) . The time window after ischemia induction Fig. 1 -Lesion regions. Illustration showing ischemic lesion extension observed in our experiment, with two regions identifiable after seven post-ischemic days. White line indicates the limit between core and boundary zones, and black line indicates the cortical limit of the lesion (represented in gray). The core zone is characterized by greatly altered cytoarchitecture, often with large spaces formed by tissue cleaning (not shown). The boundary zone presents more preserved cell organization, favoring a better cytological analysis. The lateral-medial axis is indicated for the left hemisphere. STR = striatum; V = lateral ventricle; CC = corpus callosus.
was a week, when the level of cortical tissue degeneration is greatly advanced, as previously described by Szele et al. (1995) . Differences in the level of cytoarchitecture impairment led us to recognize two main lesion zones: a core zone, with great level of tissue degeneration, and a boundary zone, with less tissue disorganization, which favored histological analysis (Fig. 1) . Although Man-BSA + (Fig. 2B ) and MR + (not shown) cells have been observed in the lesion core zone, the high level of cell degeneration and cytoarchitecture impairment hindered double-labeling visualization in this region. We focused our double-labeling analyses in the less degenerated lesion boundary zone. We performed these analyses in BMMCs and control (ischemic-untreated) animals. No qualitative difference in pattern of labeling was observed between groups.
A C-type lectin receptor (MR) is active in the ischemic lesion
Labeling with Man-BSA revealed a large number of positive cells within the ischemic lesion ( Figs. 2A and B) . Stained cells always presented spherical (amoeboid) morphology, and were not observed in unimpaired cortical parenchyma. Out of the lesion, Man-BSA + cells were only observed in meningeal space and had no relation to lesion, since they were observed along the whole cerebral cortex, in both hemispheres (Fig. 2C ).
Labeling with an anti-MR antibody (against a C-terminal peptide) revealed a similar pattern of expression, although with a much lower number of stained cells in the lesion core zone and in the meningeal space (not shown).
2.2.
MR is expressed by GFAP + cells and phagocytic macrophages/microglia in the lesion boundary zone
To characterize MR-expressing cell types within the ischemic lesion, double-labeling analyses were performed. Lack of Man-BSA and MR labeling in unaffected cortical parenchyma and the constant spherical morphology of labeled cells led us to disconsider neurons as a possible identity. By previous reports, oligodendrocytes do not express MR (Burudi and Régnier-Vigouroux, 2001) , and this cell type was also disregarded. We evaluated if these cells are reactive astrocytes by double-labeling with anti-GFAP. As expected in rodents (but not humans, see Liu et al., 2004) To confirm morphological criteria, phagocytic macrophages/microglia were identified using an antibody directed 
Ischemic lesion and treatment with BMMCs induced increased expression of MR in injured cortex
Double-labeling analyses were useful for qualitative analysis and showed clear evidence of increased MR expression within Photomicrographs of a same field illustrating, in higher magnification, the lesion boundary zone shown in C1-4. Arrow points an example of double-labeled cell. Scale bar in D4 = 20 μm.
the lesion in relation to unimpaired parenchyma. However, the complex pattern of staining hampered an accurate selection of image fields and standardization of sample for quantification by cell counting or densitometric analysis. For this reason, to verify the effect of BMMC treatment in the level of MR protein expression, we performed quantitative analysis by densitometric measurement of protein bands obtained in immunoblotting procedure (Fig. 6 ). Statistical analysis revealed no significant interaction between factors (side × treatment; F = 6.29; p = 0.07), and significant effects of side (F = 45.75; p < 0.01) and treatment (F = 19.42; p < 0.05). Comparisons among sides showed significantly more MR protein in ipsilateral than in contralateral cortex, in both groups (Figs. 6B and C) . No significant difference was observed between BMMCs and control contralateral cortices (p = 0.23) (Fig. 6C) , and this low expression was not different from ipsilateral and contralateral cortices of non-operated animals (Fig. 6B) . Furthermore, comparison between ipsilateral cortices revealed a significantly greater quantity of MR protein in BMMC group (Figs. 6B and C) . These results show that a sizeable MR expression was induced within the lesion, and that in BMMC-treated animals this expression was increased.
Discussion
We observed a largely increased MR expression within the ischemic cortical lesion a week after ischemia induction. Unimpaired cortical parenchyma presented no detectable expression in histological analysis and low expression in immunoblotting assay. These results suggest that ischemia induces a high expression of this receptor in damaged tissue. We labeled MR by two ways, which showed similar pattern of staining, particularly in the lesion boundary zone, although with differences in the number of stained cells in the lesion core zone and in meningeal space. Antibody anti-MR revealed MR protein, and mannosylated neoglycoprotein revealed the presence of a mannose receptor, i.e., its ability to bind to a specific ligand. Thus, in addition to a conclusion that MR expression is largely induced by ischemia, we can also infer that MR (and/or a member of its family) is found in a chemically active form. Mannosylated residues are also recognized by other members of the C-type lectin receptor superfamily (Linehan et al., 1999) . However, the expression of these other members is not expected in our experiments, since expression of Endo180 is predominantly restricted to cells of These cells presented typical morphology of phagocytic (amoeboid) microglia. Scale bars = 20 μm.
mesenchymal origin, in particular stromal fibroblasts (Engelholm et al., 2009 ) and Dec 205, tested in parallel with MR, was not reported in the brain (Linehan et al., 1999) . Furthermore, we used an isolation method that eliminates unwanted cell types present in marrow aspirate, of which a small percentage (estimated at about 0.001 to 0.01%) grow as fibroblastic cells (mesenchymal stem cells; Pittenger et al., 1999) . Previous reports demonstrated that MR expression in murine brain is higher in the first week of life and dramatically decreases thereafter, being maintained at a low level throughout adulthood. During development and postnatal age, sites of most intense expression are meninges, followed by cerebral cortex, brain stem and cerebellum. With age, this expression tends to be maintained in a region such as the cerebral cortex and brain stem, although it disappears from others such as the hippocampus (Burudi and Régnier-Vigouroux, 2001 ). Furthermore, MR is mainly expressed by meningeal and parenchymal perivascular macrophages (Galea et al., 2005) , besides also by neurons and astrocytes (Burudi and Régnier-Vigouroux, 2001 ). Galea et al. (2005) demonstrated that after induction of different types of inflammatory lesions in cerebral parenchyma, MR expression still remains restricted to perivascular macrophages, and activated microglia and invading hematogenous leukocytes are MR negative. They argued that perivascular macrophages might remain in vascular niche, or they might loose MR expression after migration to the inflamed region. We showed discrepant results, since we observed a large MR expression within the ischemic cortical lesion, which is known to induce intensive inflammatory tissue response (Huang et al., 2006) . And part of MR positive cell population within the ischemic lesion was undeniably phagocytic macrophages/microglia. We are not able to explain these different results, but it might represent differences in physiopathological characteristics among our model of ischemia and the different protocols of lesion used in the previous Although not quite compact, bands were located around the correct position for the MR protein molecular weight (180 kDa). No other band was detected along the lines. Note increased MR protein expression in ipsilateral region (ipsi) in BMMCs and control groups. Contralateral region of BMMCs and control groups showed lower MR expression, similar to that observed in normal animals. The numbers in parentheses mean an arbitrary identification for each animal in each group used in this experiment. (C) Bar graph summarizing the densitometric analysis of the bands. Statistical analysis revealed significant higher MR expression in ipsilateral than in contralateral region in both groups. Furthermore, the comparison between ipsilateral regions revealed higher MR expression in BMMCs than in control group. In (A): STR = striatum; V = lateral ventricle; CC = corpus callosus. In (C): BMMC group, n = 3; control group, n = 3; each vertical bar + error bar = mean + S.E.M; * = p <0.05, t test).
work. Other possible explanation might be the different postlesion induction survival times spent until animal sacrifice used in each work.
Microglia, astrocytes, immature neurons, olfactory ensheathing cells and Schwann cells express MR (Baetas-daCruz et al., 2009a; Liu et al., 2004; Macedo-Ramos et al., 2011; Régnier-Vigouroux, 2003) but there is no evidence that either mature oligodendrocytes or their precursors express it (Burudi and Régnier-Vigouroux, 2001; Galea et al., 2005) . These data led us to look for microglial and astrocytic identities for MR expressing cells found within the lesion boundary zone. As said above, our double-labeling confirmed that part of the MR expressing cells were phagocytic macrophages/ microglia. We also found a MR expressing GFAP + cell population specific of the lesion boundary zone, but their morphology was not indicative of reactive or other known type of astrocyte. We are not able to classify this GFAP + cell population, but in the light of recent reports, these cells might correspond to perilesional NG2 cells-derived GFAP + cells, described after neocortical stab wound injury (Komitova et al., 2011) . Moreover, they might also correspond to pericytes scar forming migrated from parenchymal perivascular niche (Göritz et al., 2011) and/or ischemia-induced neural stem/progenitor cells migrated from meningeal perivascular niche (Nakagomi et al., 2011) . But in these two last hypotheses, we might suppose transdifferentiation in a GFAP expressing cell type, since they were not found to be GFAP + (Göritz et al., 2011; Nakagomi et al., 2011) . Further investigations are necessary to clarify the real identity of these cells. We cannot exclude the possibility that part of MR expressing cells are formed by administered BMMCs. However, the number of these hypothetical MR-expressing BMMCs is likely to be very low, since it has been shown that BMMCs are found within the ischemic lesion 1 h after injection, and then undergo progressive death until they are almost absent after 7 days (Brenneman et al., 2010) . We have previously demonstrated in the same model of ischemia that treatment with BMMCs promoted significant sensorimotor functional recovery and decreased neurodegeneration in the periphery of the ischemic lesion (GiraldiGuimarães et al., 2009 ). Here we observed that BMMCs seem to promote overexpression of MR in ipsilateral (impaired) cortex. Together, previous and current data might suggest functional relation between functional recovery, decreased neurodegeneration and increased MR expression. MR involvement in clearance has been already demonstrated, since there are evidences showing that MR might interact with other pattern recognition receptors (PRRs) to mediate signal transduction pathways (Gazi and Martinez-Pomares, 2009 ). PRRs can recognize dying cells through damage-associated molecular patterns (DAMPs), and this recognition depends on changes in membrane phospholipids or glycoproteins via alterations in glycation patterns (Bianchi, 2007; Miller et al., 2011) . DAMPs are also considered important in embryogenesis, when apoptosis is prominent (Bianchi, 2007) . Molecules and cellular components potentially found in areas of trauma that can bind to MR include lysosomal enzymes, tissue plasminogen activator, red blood cells, factor X, complement protein iC3b and fibrinogen (Ishihara et al., 1998; Issekutz et al., 1999; Taylor, 1993) . Furthermore, a recent study provides evidence that the calcium-binding protein oncomodulin, combined with elevated cAMP and presence of D-mannose, is important to promote retinal ganglion cell regeneration following optic nerve injury (Benowitz and Yin, 2010) . Involvement of mannose ligands was not investigated, but the need for D-mannose presence might suggest activation of MR and its possible promoting effect in axonal regeneration. These data highlight an interesting paradox concerning mannose receptors, because it is also known that mannosylated ligands are capable of inducing a macrophage state that leads to axonal injury through the cavitation mediated by astrocytes (Fitch et al., 1999) .
Thus, our results suggest that induction of overexpression of MR within the ischemic lesion by BMMC treatment might contribute to the restorative effect of these cells, since MR is part of a mechanism for clearance of DAMPs, such as soluble immune components, cell debris, cytotoxic substances, myelin glycoproteins and degrading enzymes. More effective clearance might turn damaged tissue more permissive to plastic changes and regeneration of affected neuronal projections. Furthermore, it might also remove more efficiently toxic molecules, contributing to decreased neurodegeneration in periphery of the cortical lesion after BMMC treatment observed in our previous work (Giraldi-Guimarães et al., 2009) .
The mechanism of action of bone marrow-derived cells has been described to involve migration to the site of injury and engrafting. Furthermore, three mechanisms might also be involved: cell fusion, differentiation (or "transdifferentiation") into neural cell types and releasing of many trophic factors, cytokines and extracellular matrix components into the ischemic lesion (Chopp and Li, 2002; Maltman et al., 2011) . The role as a "factory" of trophic factors and extracellular matrix molecules has been shown to be the most promising action, promoting angiogenesis, neuroprotection (reduction of apoptosis), modulation of inflammatory response, reduction of glial scar and facilitation of axonal regeneration and plastic rewiring of neuronal connections (Chopp and Li, 2002; Crain et al., 2005; Krause et al., 2001; Li et al., 2005; Maltman et al., 2011; Shyu et al., 2006) . Our results seem to include a new putative mechanism, since the increasing of clearance might also be taking place. However, more studies should be performed to elucidate this question.
Taken together, our data suggest a possible involvement of MR in a regenerative mechanism, through efficient removal of cellular debris and inflammatory components, triggered by damage process in acute phase of brain injury.
4.
Experimental procedures
Animals and chemicals
Albino Wistar rats with ages ranging from 2 to 5 months were used in the present study. All animals were housed in a colony room with controlled temperature, and with food and water available ad libitum. Our experiments were carried out in accordance with National Institute of Health Guide for the Care and Use of Laboratory Animals (NIH Publications No. 80-23), and were approved by the Committees for Use of Experimental Animals of our institutions.
Enhanced chemiluminescence (ECL) kit and secondary antibodies conjugated to horseradish peroxidase (HRP) were obtained from Amersham Pharmacia Biotech (São Paulo, Brazil). Most of reagents and chemicals were purchased from SigmaAldrich Co. (St. Louis, MO, USA). Exceptions are indicated in the text.
Surgical procedures
Ischemic lesion was induced by thermocoagulation of blood into pial blood vessels of primary motor and somatosensory cortices, as previously described (de Vasconcelos dos Santos et al., 2010; Giraldi-Guimarães et al., 2009) . Briefly, animals were anesthetized with ketamine hydrochloride (100 mg/kg, i.p.) and xylazine hydrochloride (10 mg/kg, i.p.) and placed in a stereotaxic apparatus. A craniotomy was made to expose left frontoparietal cortex (+2 to − 6 mm from bregma in antero-posterior axis; according to the atlas of Paxinos and Watson, 1998) . Superficial blood vessels were thermocoagulated transdurally by approximation of a hot probe to dura matter. Skin was then sutured and animals were kept warm under a hot lamp and returned to the colony room after recovery from the anesthesia.
Obtainment and transplantation of BMMCs
Bone marrows were obtained from donor normal albino Wistar rats. Animals were anesthetized with ketamine hydrochloride (100 mg/kg, i.p.) and xylazine hydrochloride (10 mg/ kg, i.p.) and then sacrificed. Femoral and tibial bones were dissected and their bone marrows were extracted with serumfree DMEM-F12 (GIBCO BRL, Grand Island, NY, USA). Bone marrow cells were mechanically dissociated and separated by centrifugation for 30 min in Histopaque. BMMCs were collected, washed and resuspended with phosphate-buffered saline (PBS). All ischemic animals were injected into the left jugular vein approximately one day after ischemia induction. In a group of animals (BMMC group; n = 6) each animal was injected with 500 μl of PBS containing 3 × 10 7 cells, and in another group (control group; n = 6) each animal was injected with 500 μl of PBS. This cell dose was chosen since it has been shown in the literature that systemic treatment with 1-3 × 10 7 cells is effective to promote recovery, including previous studies from our research group (de Vasconcelos dos Santos et al., 2010; Giraldi-Guimarães et al., 2009; Iihoshi et al., 2004; Kamiya et al., 2008; yang et al., 2011) .
Histological procedures and double-labeling
After seven post-ischemic days, three animals from each experimental group were sacrificed and intracardially perfused with 0.9% NaCl solution followed by 4% paraformaldehyde, in 100 mM phosphate buffer (pH 7.4). Brains were removed and immersed in 100 mM phosphate buffer containing 20% sucrose for 24 h at 10°C. Brains were sectioned in the coronal plane at 30 μm of thickness at −20°C on a CM 1850 cryostat (Leica Instruments GmbH, Heidelberg, Baden-Wurttemberg, Germany). Sections were then washed in PBS and preincubated in PBS + 0.3% Triton X-100 with 10% normal goat serum for 60 min at room temperature. After that, they were incubated overnight at 10°C in the same solution to which pairs of specific markers were added. After washing with PBS, bound primary makers were revealed by incubation with correspondent secondary markers in PBS for 2 h at room temperature. All sections were counterstained with 4′,6-diamidino-2-phenylindole (DAPI). Table 1 summarizes used primary and secondary markers. Pairs of markers used for double-labeling are described in the Results section. A histochemical assay with fluorescein isothiocyanate (FITC)-conjugated mannosylated bovine serum albumin (Man-BSA) binding was performed in order to verify the presence of a mannose receptor with the active C-type lectin-like domains (CTLDs). Some sections were washed in Ringer solution and incubated with 50 μg/ml Man-BSA diluted in Ringer solution containing 5 mM CaCl 2 plus 1% BSA at 37°C for 1 h. Controls were obtained by incubation of the sections with 250 mM D-mannose or~1.1 μM HRP diluted in the same labeling solution followed by washing and incubation with 50 μg/ml Man-BSA, as previously described (Baetas-da-Cruz et al., 2009b) . Regarding MR protein staining, we used two different sera (kindly donated by Dr. Anne Régnier-Vigouroux). One, generated against MR C-terminal cytoplasmic portion, has worked better in immunohistochemistry (IHC) than in western blot assays in previous tests from our collaborators, and was used for double-labeling (Table 1) . The other, which was made using the whole molecule and that recognizes an extracellular epitope (called K1K2 antibody), has worked better in western blot than in IHC. Thus K1K2 antibody was used in immunoblotting analysis, as described below.
Electrophoresis (SDS-PAGE) and immunoblotting
After seven post-ischemic days, three animals of both experimental groups were sacrificed for the quantification of MR protein by immunoblotting. Normal (non-operated) animals were also sacrificed and used in this analysis. Animals were decapitated under deep anesthesia and their brains were removed from the skull. In ischemic animals, the cortical tissue located between the lesion, the cerebral longitudinal fissure (ipsilateral region) and the contralateral cortex homologous to the lesioned cortex (contralateral region) were dissected separately (Fig. 6A) . In normal animals, the same regions were separately dissected (left cortex located between the presumptive place of the lesion and the longitudinal fissure and right cortex homologous to the presumptive place of the lesion). Care was taken to dissect only the six cortical layers (gray matter). Tissues were then homogenized at 4°C in a lyses buffer containing 20 mM Tris-HCl (pH 7.0), 150 mM NaCl, 2 mM ethylenediaminetetraacetic acid (EDTA), 0.2% triton-X-100, 10 μg/ml leupeptin, 10 μg/ml soybean trypsin inhibitor and 2 μg/ml aprotinin. Thus, each animal generated two homogenates (ipsilateral and contralateral sides). All homogenates were centrifuged at 4°C and the supernatants were collected to be used in electrophoresis. Protein concentration of supernatants was determined by the Bradford's technique. For each supernatant, a sample containing 30 μg of protein was collected and mixed with electrophoresis sample buffer containing 50 mM Tris-HCl (pH 6.8), 2% (w/v) sodium dodecyl sulfate (SDS), 5% (v/v) β-mercaptoethanol and 10% (v/v) glycerol. All samples were boiled for 4 min prior to loading in a 12.5% SDS-polyacrylamide gel. Mini-PROTEAN 3 Electrophoresis Module (BioRad Laboratories Inc., Hercules, CA, USA) was used. After separated in gel, proteins were transferred to nitrocellulose membranes (0.45 μm pore), which were blocked in PBS-tween (0.05% tween-20 in 10 mM PBS) containing 5% skimmed powdered-milk for 1 h. Membranes were incubated in the same solution added by K1K2 antibody (against MR protein; rabbit IgG polyclonal; dilution 1:1000). After washes in PBS-tween, membranes were incubated with HRP-conjugated secondary antibody (goat anti-rabbit; dilution 1:3000, in PBStween) for 2 h. After washes in PBS-tween, immunoreactive bands were then visualized by films impregnated using ECL kit, in accordance to manufacturer's instructions.
Data analysis
Sections reacted for double-labeling were analyzed under fluorescent illumination in an Axioplan microscope (Carl Zeiss Inc., Germany), using fluorescein, rhodamine and DAPI filters. Color images were captured using a Zeiss AxioCam digital camera connected to this microscope and to a PC computer with Zeiss Axiovision 4.8 Software. For illustration, grayscale conversion, brightness/contrast adjustments and artwork were made using Adobe Photoshop software (Adobe Systems Inc., San Jose, CA, USA). Films obtained in immunoblotting procedure were scanned to capture their images. Optical density (OD) of each immunoblot was measured using the NIH ImageJ 1.44b software. For each side of each animal, final value was: blot OD minus film background OD. All images were analyzed without any modification. For illustration, grayscale conversion and artwork were made using Adobe Photoshop software (Adobe Systems Inc., San Jose, CA, USA).
For statistical analysis, repeated measures two-way ANOVA ("side" versus "treatment"; side as the matched factor) was used. Paired t test was used for comparisons among sides inside each group, and unpaired t test for comparisons among groups inside each side. Level of significance was always set at p < 0.05.
